Cramer believes this recently separated stock that supports food production is a good investment. Here’s the reasoning.

Cramer believes this recently separated stock that supports food production is a good investment. Here’s the reasoning.

Jim Cramer’s Insights on Corteva and Vylor Stocks

On Friday, Jim Cramer, from CNBC, shared his thoughts on agriculture companies Corteva and its newly spun-off counterpart, Vylor. The recent restructuring saw Corteva, which specializes in agriculture, split off Vylor into an independent entity this week.

Corteva, originally part of DowDuPont’s unraveling back in 2019, has performed admirably since becoming a standalone company, with its shares tripling. This week’s separation marks an attempt to replicate that success. Corteva has shifted its focus toward crop protection, while Vylor will handle advanced seed and genetics.

Though both companies share many of the same customers, their economic profiles differ significantly. Cramer expressed a strong preference for Vylor, stating, “Corteva needs to prove itself before I’m willing to get on board a crop protection play. I like this Vylor right now.” He pointed out that the genetically modified seeds sector is lucrative, in contrast to the more commodity-like nature of crop protection. His favored chemicals analyst, Frank Mitsch from Fermium Research, views Vylor as the standout in this split, whereas Corteva has become more of a “show-me story,” despite having capable management.

Vylor’s advantages include a substantial research operation dedicated to developing seed traits, which are then licensed to other producers for royalties. The company is also contemplating around $1 billion in annual stock buybacks from 2027 to 2029, alongside a modest dividend. Cramer noted, “Regular viewers know I like big buybacks.” However, he cautioned that Vylor isn’t exactly a bargain, trading at over 30 times the current year’s expected earnings and more than 25 times for the following year. He thinks the premium is justified, but it does reduce their margin for error.

Turning to Corteva, Cramer mentioned that it trades at 23 times the current year’s earnings estimates and 20 times next year’s, commenting, “There’s a reason for that,” as Corteva is seen as the more stagnant segment of the business.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News